Ed Michael
Managing Partner @ LionBird
Chicago, United States
Ed Michael is a seed investor at LionBird in Chicago focused on Medical and Robotics. Ed co-founded LionBird following a 25-year career at Abbott Laboratories where he served as Executive Vice President of Diagnostic Products, overseeing over $4B in revenues and 13,000 employees. Previously he held various commercial and operational leadership positions in the company. Ed served on the Board of Directors at Cook County Health andHospitals System from 2012-2013, and currently serves on the Boards of NeuMoDx, a molecular diagnostics company, and several LionBird portfolio companies. He earned his BA in politics and government and a juris doctorate from Indiana University in Bloomington
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Ed Michael invests in
Stages Ed Michael invests in
Countries Ed Michael invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (33%)
- Robotics 1 (33%)
- Wellness 1 (33%)
- Health Care 1 (33%)
- Neuroscience 1 (33%)
Stage
- Seed 2 (67%)
- Series A 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Phantom Neuro
|
Phantom Neuro develops innovative muscle-machine interfaces that enhance robotic limb rehabilitation. The company focuses on creating solutions that improve mobility for users by integrating neurotechnology with robotic systems. Through its minimally invasive approach, Phantom Neuro aims to facilitate precise control of robotic limbs, allowing formore natural movement and better user experiences. The company is committed to advancing the field of neurotechnology, providing valuable tools for rehabilitation and improving the quality of life for individuals with mobility challenges. Phantom Neuro also explores various applications of its technologies, contributing to the broader field of assistive robotics. | $19M / Series A / Apr 15, 2025 | |
PatientPartner
|
PatientPartner personalizes the patient journey by leveraging real-world experiences, educating and guiding patients to make informed medical decisions through connections with doctors, mentors, and physicians. By combining artificial intelligence and machine learning with personalized human connections, the company creates relatable experiencesbetween patients, providers, and industry partners all in one place. Our vision is to create a platform where the world comes to understand their health. A future where all of healthcare can be found on a single platform that is focused on ensuring patients get the care and experiences they deserve. We work with physicians, healthcare institutions and medical technology companies across all healthcare verticals to bring new motivated patients into their clinics, reduce patient drop off, and collect long-term patient outcome data to better identify future patient needs and create better experiences. | $3.5M / Seed / Sep 04, 2024 | |
|
Phantom Neuro
|
Phantom Neuro develops innovative muscle-machine interfaces that enhance robotic limb rehabilitation. The company focuses on creating solutions that improve mobility for users by integrating neurotechnology with robotic systems. Through its minimally invasive approach, Phantom Neuro aims to facilitate precise control of robotic limbs, allowing formore natural movement and better user experiences. The company is committed to advancing the field of neurotechnology, providing valuable tools for rehabilitation and improving the quality of life for individuals with mobility challenges. Phantom Neuro also explores various applications of its technologies, contributing to the broader field of assistive robotics. | $3.3M / Seed / Mar 25, 2022 |
Co-Investors
About LionBird
LionBird is a Tel Aviv- and Chicago-based venture capital firm investing in early-stage software companies operating in the healthcare, commerce, and enterprise sectors. Founded in 2012, LionBird has developed an investment strategy around early-stage startups that leverages online technology to re-imagine traditional offline business processes andmodels.
LionBird Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Chaim Friedman
Founding Partner
|
|||
|
Ed Michael
Managing Partner
|
|||
Eric Fenster
Solo Legal Counsel / Partner
|
|||
Gal Noyman Veksler
Principal
|
|||
Itschak Friedman
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Ed Michael invest in?
Ed Michael invests primarily in Medical, Robotics and Wellness startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ed Michael?
Public channels for Ed Michael include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Ed Michael last invest?
The most recent investment recorded for Ed Michael closed in Apr 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
